Elif Oztürk

ORCID: 0009-0005-1245-0206
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis C virus research
  • Gallbladder and Bile Duct Disorders
  • Pneumonia and Respiratory Infections
  • Liver Disease Diagnosis and Treatment
  • Synthesis and biological activity
  • Pancreatitis Pathology and Treatment
  • HIV/AIDS drug development and treatment
  • Chemical Synthesis and Analysis
  • Gastroesophageal reflux and treatments
  • Click Chemistry and Applications

Erzincan University
2024

Bolu Abant İzzet Baysal University
2005

HCV virus infections are one of the major health problems in world that can cause cirrhosis and liver cancer at a higher rate than other hepatitis data. The aim this study was to determine prevalence mixed with different genotypes Turkey also evaluate current genotype sub-type distributions by multicentered assessment.The data 17,578 C patients collected from 23 centers geographic regions covering all were collected. included information about last 10 years (between 2007 2016), demographic...

10.7754/clin.lab.2018.180824 article EN Clinical Laboratory 2019-01-01

Multidrug-resistant Mycobacterium tuberculosis strains' increasing emergence and rapid spread necessitate the urgent development of innovative antimycobacterial agents. In pursuit novel agents, a series N-(benzazole-2-ylmethyl)-2-substituted phenylacetamide or N-(benzazole-2-ylmethyl)-2-(thiophen-2-yl)acetamide compounds (6-11) were synthesized. Their efficacy against multidrug-resistant was assessed. Compounds exhibited potent activity with minimum inhibitory concentrations (MIC) ranging...

10.18185/erzifbed.1480781 article EN Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2024-08-27

We report the case of a 73-year-old female patient with diabetic nephropathy and cholelithiasis. She was admitted to our hospital right upper abdominal pain, nausea, vomiting. The had visited an outpatient clinic same complaints 2 days earlier, been prescribed antibiotics empirically (two doses ofloxacin orally). Blood cultures taken before start antibiotic treatment in were negative. treated parenteral ampicillin/sulbactam + ciprofloxacin empirically. empiric discontinued after 7 days....

10.7883/yoken.jjid.2005.34 article EN Japanese Journal of Infectious Diseases 2005-02-28
Coming Soon ...